Chantix Study Finds Little Evidence to Support Suicidal, Criminal Warnings
But quit-smoking drug may be linked to other adverse effects Source: HealthDay Related MedlinePlus Pages: Drug Safety, Medicines, Quitting Smoking (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - June 3, 2015 Category: Consumer Health News Source Type: news

Chantix Study Finds Little Evidence to Support Suicidal, Criminal Warnings
Title: Chantix Study Finds Little Evidence to Support Suicidal, Criminal WarningsCategory: Health NewsCreated: 6/2/2015 12:00:00 AMLast Editorial Review: 6/3/2015 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - June 3, 2015 Category: Respiratory Medicine Source Type: news

No evidence that smoking drug linked to increased risk of suicide or traffic accidents
There is no strong evidence that the popular smoking cessation drug varenicline is associated with increased risks of suicidal behaviors, criminal offending, transport accidents, traffic-related offenses, and psychoses, finds a study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 3, 2015 Category: Science Source Type: news

Entrepreneur Touts Cheap, Safe Smoking Cessation Drug -- But Is It?
Thus, is this product going to live up to its promise of a safer alternative to current treatments like Chantix and buproprion? Perhaps - but that still needs to be proven. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 18, 2015 Category: Pharmaceuticals Authors: John LaMattina Source Type: news

Extended Varenicline in a Severely Cardiopathic SmokerExtended Varenicline in a Severely Cardiopathic Smoker
Varenicline has been associated with an increased risk of cardiovascular adverse events in high-risk patients, but this case demonstrates that it can be safely used long-term with careful monitoring. Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 10, 2015 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

No Suicide Risk With Varenicline?No Suicide Risk With Varenicline?
A comprehensive meta-analysis shows no evidence of neuropsychiatric effects of varenicline, but the study has its detractors. Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - March 23, 2015 Category: Psychiatry Tags: Psychiatry News Source Type: news

Largest review of clinical trials to assess risk of patients using Varenicline
Findings from the largest review of clinical trials to date to determine whether patients prescribed the smoking cessation drug Varenicline (brand name Champix in the UK) are at an increased risk of neuropsychiatric events are have been published. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 12, 2015 Category: Science Source Type: news

Largest review of clinical trials to date finds no increased risk of suicide in patients using Champix
Findings from the largest review of clinical trials to date to determine whether patients prescribed the smoking cessation drug Varenicline (brand name Champix in the UK) are at an increased risk of neuropsychiatric events are published online in the British Medical Journal [BMJ] today [12 Mar]. The study was carried out by researchers at the University of Bristol. (Source: University of Bristol news)
Source: University of Bristol news - March 12, 2015 Category: Universities & Medical Training Tags: International, Research; Faculty of Medicine and Dentistry, School of Social and Community Medicine, Institutes, Elizabeth Blackwell; Press Release Source Type: news

News in Brief: Week of March 9-13
This roundup includes the following news briefs: FDA: Use Caution Mixing Chantix, Alcohol; VA Accelerates Deployment of Nationwide Opioid Therapy Tool; FDA Backs WHO Recommendations for 2015-16 Flu Vaccine Composition; Join HHS Network, Help Move Health Care Toward Value-based Payments; and Harvard Medical School Announces Inaugural InciteHealth Fellows. (Source: AAFP News)
Source: AAFP News - March 12, 2015 Category: Primary Care Source Type: news

Largest review of clinical trials to assess risk of patients using Champix
(University of Bristol) Findings from the largest review of clinical trials to date to determine whether patients prescribed the smoking cessation drug Varenicline (brand name Champix in the UK) are at an increased risk of neuropsychiatric events are published online in the British Medical Journal today. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 12, 2015 Category: Global & Universal Source Type: news

FDA Warns of Seizure, Alcohol Risk With Chantix
Title: FDA Warns of Seizure, Alcohol Risk With ChantixCategory: Health NewsCreated: 3/11/2015 12:00:00 AMLast Editorial Review: 3/11/2015 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - March 11, 2015 Category: Respiratory Medicine Source Type: news

FDA Warns of Seizure, Alcohol Risk With Chantix
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - March 11, 2015 Category: Journals (General) Source Type: news

New FDA warning for anti-smoking drug Chantix
Drug already comes with a warning of suicidal or violent behavior, and now there's something else to be wary of (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - March 11, 2015 Category: Consumer Health News Source Type: news

FDA: Chantix Carries Potential Alcohol Interaction and Seizure Risk (FREE)
By Kristin J. Kelley Edited by Lorenzo Di Francesco, MD, FACP, FHM The FDA has approved a label change to varenicline (Chantix) to warn that the smoking cessation drug could "change the way people react to alcohol." Additionally, the label … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 11, 2015 Category: Primary Care Source Type: news

Quitting smoking? FDA flags alcohol, seizure risks for Chantix users
The U.S. Food and Drug Administration is warning smokers who are trying to quit that they may have trouble tolerating alcohol if they are taking Chantix. (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - March 10, 2015 Category: Science Source Type: news